Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10259887 Heterodimeric antibodies that bind CD3 and tumor antigens

Patent 10259887 was granted and assigned to Xencor on April, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 30 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 30 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12129309 Heterodimeric antibodies that bind CD3 and CD38
0
Edits on 12 Mar, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 12 Mar, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11919956 Heterodimeric antibodies that bind prostate specific membrane antigen (PSMA) and CD3
0
Edits on 9 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 9 Dec, 2023
Edits made to:
Article (+83 characters)
Article

Patent abstract

The present invention is directed to novel heterodimeric antibodies.

Edits on 2 Oct, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 2 Oct, 2023
Edits made to:
Infobox (+7 properties)
Infobox
Patent Inventor Names
Gregory Moore0
John Desjarlais0
Matthew J. Bernett0
Rumana Rashid0
Seung Chu0
Sung-Hyung Lee0
Umesh Muchhal0
Edits on 18 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 18 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=102598870
Edits on 23 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 23 Apr, 2023
Infobox
Patent Citations Received
‌
US Patent 10858417 Heterodimeric proteins
0
Edits on 7 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 7 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Xencor
Xencor
0
Current Assignee
Xencor
Xencor
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
102598870
Date of Patent
April 16, 2019
0
Patent Application Number
151413500
Date Filed
April 28, 2016
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=102598870
Patent Citations Received
‌
US Patent 10793632 Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors
0
‌
US Patent 10858417 Heterodimeric proteins
0
Patent Primary Examiner
‌
Sean D Aeder
0
Edits on 27 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Sep, 2022
Edits on 18 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 18 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=10259887
Edits on 8 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 8 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10858417 Heterodimeric proteins
Edits on 7 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Feb, 2022
Edits on 25 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 25 Jan, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 10259887 Heterodimeric antibodies that bind CD3 and tumor antigens

Infobox
Is a
Patent
Patent
Patent applicant
Xencor
Xencor
Current assignee
Xencor
Xencor
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10259887
Date of patent
April 16, 2019
Patent application number
15141350
Date Filed
April 28, 2016
Patent primary examiner
‌
Sean D Aeder

Find more entities like US Patent 10259887 Heterodimeric antibodies that bind CD3 and tumor antigens

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo